Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women

被引:0
作者
N. Tentolouris
G. Christodoulakos
I. Lambrinoudaki
E. Mandalaki
C. Panoulis
C. Maridaki
G. Creatsas
N. Katsilambros
机构
[1] Laiko Hospital,Department of Propedeutic Medicine
[2] Aretaieion Hospital,2nd Department of Obstetrics and Gynecology
[3] Athens University Medical School,undefined
来源
Journal of Endocrinological Investigation | 2005年 / 28卷
关键词
Hormone therapy; estrogen; pulse wave analysis; aortic pressure;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study was to assess the effect of continuous hormone therapy (HT) for 1 yr on pulse wave analysis and central aortic pressure in healthy postmenopausal women. Sixty-five healthy postmenopausal women were randomly allocated to receive either conjugated equine estrogens 0.625 mg plus medroxyprogesterone acetate 5 mg (CEE/MPA, Premelle 5, Wyeth — Ayerst Lab, Philadelphia, PA, no.=32) or no therapy (no.=33). Treatment was continuous, and the study period lasted 12 months. Central aortic pressure, augmentation and augmentation index (AI) were determined non-invasively using applanation tonometry. All measurements were performed at baseline and at the end of the study by the same person. Ns differences were found between baseline values and values at the end of the study in either the control or the CEE/MPA group in central systolic aortic pressure (107.0±13.1 vs 107.6±11.3 mmHg, p=0.80, and 110.8±10.8 vs 112.3±11.4 mmHg, p=0.23, respectively), augmentation (12.6±4.2 vs 11.9±4.8 mmHg, p=0.45 and 11.7±3.7 vs 12.6±4.2 mmHg, p=0.34, respectively), and percentage of AI (36.8±9.3 vs 36.3±10.3, p=0.81 and 34.1±8.9 vs 34.9±9.8, p=0.72, respectively). The results of this preliminary report suggest that HT for 1 yr does not have any significant effect on central aortic pressure and wave reflection in healthy postmenopausal women.
引用
收藏
页码:305 / 311
页数:6
相关论文
共 172 条
[1]  
Arnett DK(1994)Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 140 669-82
[2]  
Evans GW(1998)Recent advances on large arteries in hypertension Hypertension 32 156-61
[3]  
Riley WA(1997)Sex differences in coronary heart disease Why are women so superior? The 1 995 Ancel Keys Lecture. Circulation 95 252-64
[4]  
Safar ME(1990)Estrogen modulates responses of atherosclerotic coronary arteries Circulation 81 1680-7
[5]  
London GM(1999)Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen J Clin Invest 103 401-6
[6]  
Asmar R(1994)Human vascular smooth muscle cells contain functional estrogen receptor Circulation 89 1943-50
[7]  
Frohlich ED(1991)Estrogen and coronary heart disease in women JAMA 265 1861-7
[8]  
Barrett-Connor E(2002)HERS Research Group Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288 49-57
[9]  
Williams JK(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial JAMA 288 321-33
[10]  
Adams MR(2003)Clinical review 162: cardiovascular endocrinology: an epidemiologist looks at hormomes and heart disease in women J Clin Endocrinol Metab 88 4031-42